Clinical Trial

Improving Low ASPECTS Stroke Thrombectomy

Study acronym: I-LAST
Recruiting
View on ClinicalTrials.gov →
Summary
Improving Low ASPECTS Stroke Thromectomy (I-LAST) is an academic, independent, prospective, multicenter, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome. Advanced imaging biomarkers will be tested and validated aiming to improve treatment selection and outcome prediction of patients presenting with extensive baseline infarction.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-04-22; most recent amendment 2023-05-23.
Status change: Not Yet Recruiting → Recruiting 2023-05-23
Trial Details
NCT Number NCT04862507
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Collaborators: University of Kaiserslautern, University Hospital Muenster, University of Rostock, University Hospital, Basel, Switzerland, Charite University, Berlin, Germany, Klinikum Bremen-Mitte, gGmbH
Conditions Acute Ischemic Stroke
Enrollment 500 participants
Start Date 2023-05-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-24